{
    "RADCURE-3408": {
        "question": "Age: 67.9, Sex: Female, ECOG PS: ECOG 0, Smoking PY: 40, Smoking Status: Ex-smoker, Ds Site: Larynx, Subsite: Supraglottis, T: T4a, N: N0, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: ChemoRT, Chemo? : Yes, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: Yes, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers. - Hierarchy: Medical Oncologist",
        "initial_assessment-medical oncologist": "The provided bounding box coordinates are identical: [267, 218, 64, 267, 258, 81]. This suggests a very thin or possibly a single-slice region along the z-axis (since the min and max z values are both 267), spanning y from 218 to 258 and x from 64 to 81.\n\nFrom a medical oncologist's perspective analyzing a head and neck CT scan:\n\n1. Anatomical Structures: The region likely corresponds to a small volume in the head and neck area, possibly including soft tissue structures such as parts of the pharynx, larynx, or adjacent soft tissues. The exact anatomical structure is difficult to specify without the image, but the coordinates suggest a localized area.\n\n2. Patterns or Abnormalities: Since the ROI is masked and limited in size, it may represent a lesion, tumor, or lymph node. The fact that the bounding box is very thin in the z-axis could indicate a small or superficial lesion or a slice capturing a specific abnormality.\n\n3. Oncologic Implications: If this ROI corresponds to a tumor or involved lymph node, its size and location are critical for staging and treatment planning. Small, localized lesions may have better prognosis and could be amenable to localized therapies such as surgery or radiotherapy, possibly combined with systemic chemotherapy or immunotherapy depending on histology and molecular markers.\n\n4. Survival Probability: Without additional clinical data (tumor type, stage, nodal involvement, metastasis, performance status), it is challenging to precisely estimate survival. However, a small, localized lesion without evidence of nodal or distant spread generally correlates with a better prognosis.\n\nFinal answer: Alive",
        "initial_assessment_review_assessment-medical oncologist": "Answer:Alive",
        "Round 1-role-comment": "medical oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-medical oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-medical oncologist": "---\nAnswer: no  \nReason: medical oncologist's scope covers systemic therapy-based survival assessment  \n---",
        "Round 2-role-comment": "medical oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Dead',)"
    }
}